Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Faricimab for macular edema secondary to branch retinal vein occlusion has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Macular Edema, Branch Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2024-01-18